CLINICAL_TRIALS ClinicalTrials.gov record update

Study Evaluating the Efficacy and Safety of Chimeric Antigen Receptor-Modified pNK Cells in MUC1 Positive Advanced Refractory or Relapsed Solid Tumor

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02839954
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:21.302186+00:00
Published At: 2016-12-06T00:00:00+00:00
Record Updated At: 2016-12-06
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Hepatocellular Carcinoma", "Non-small Cell Lung Cancer", "Pancreatic Carcinoma", "Triple-Negative Invasive Breast Carcinoma", "Malignant Glioma of Brain", "Colorectal Carcinoma", "Gastric Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2016-12-06"
protocolSection.identificationModule.nctId: "NCT02839954"
protocolSection.identificationModule.officialTitle: "Study Evaluating the Efficacy and Safety of Chimeric Antigen Receptor-Modified pNK Cells in MUC1 Positive Advanced Refractory or Relapsed Solid Tumor"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.